检索结果 - Jeffrey A. Douglas
- Showing 1 - 3 results of 3
-
1
-
2
Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer 由 Stephen A. Cannistra, Ursula A. Matulonis, Richard T. Penson, Julie Hambleton, Jakob Dupont, Howard Mackey, Jeffrey A. Douglas, Robert A. Burger, Deborah K. Armstrong, Robert M. Wenham, William P. McGuire
出版 2007Artigo -
3
A Short-Term Clinical Evaluation of L-697,661, a Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase 由 Michael S. Saag, Emilio A. Emini, Oscar L. Laskin, Jeffrey A. Douglas, William I. Lapidus, William A. Schleif, Richard J. Whitley, CAROL S. HILDEBRAND, V W Byrnes, John C. Kappes, Kevin W. Anderson, F Massari, George M. Shaw
出版 1993Artigo
相关主题
Medicine
Internal medicine
Antiretroviral therapy
Autonomy
Bevacizumab
Biology
Burnout
Cancer
Chemotherapy
Clinical psychology
Computer science
Family medicine
Gastroenterology
Gastrointestinal perforation
Gene
Genetics
Gerontology
Human immunodeficiency virus (HIV)
Job satisfaction
Law
Logistic regression
Machine learning
Multilevel model
Nucleoside
Nucleoside Reverse Transcriptase Inhibitor
Odds
Odds ratio
Oncology
Ovarian cancer
Pathology